January 3, 2025 - 12:37

Former New York City Mayor Rudy Giuliani has requested to attend his upcoming court hearing virtually, citing ongoing health issues. This request comes as Giuliani faces various legal challenges, and he believes that a remote appearance would be more suitable given his current condition.
Giuliani, who has been a prominent figure in American politics, has recently dealt with several personal and legal difficulties that have raised concerns about his well-being. His legal team has submitted the request to the court, emphasizing the importance of his health and the need for accommodations during this challenging time.
This situation highlights the increasing trend of virtual court appearances, which have become more common since the onset of the COVID-19 pandemic. Many individuals have opted for remote participation to ensure their safety and comfort while navigating the legal system. Giuliani's request will be reviewed by the presiding judge, who will determine whether to grant the virtual appearance.
April 22, 2026 - 22:06
Health Dept. report on S.F. hospital stabbing confirms Mission Local reportingSan Francisco is taking immediate action to bolster safety at public health facilities, announcing a $15 million infusion into the Department of Public Health`s security budget. This decisive...
April 22, 2026 - 01:51
WATCH: Axios Future of Health Summit 2026A major virtual gathering this week will convene leading experts to examine the transformative trends shaping medicine. The event focuses on the critical innovations and policies expected to define...
April 21, 2026 - 01:32
Former LSU QB has some health concerns leading into the draftAs the NFL Draft approaches, medical evaluations are taking center stage, with one prominent prospect facing increased scrutiny. The former LSU quarterback, widely regarded for his elite collegiate...
April 20, 2026 - 08:00
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s TrialA much-anticipated clinical trial investigating the potential of a blockbuster GLP-1 drug to slow the progression of Alzheimer`s disease has failed to meet its primary goal. The study focused on...